All data are based on the daily closing price as of December 31, 2025
a
Alfresa Holdings
2784.TSE
15.59 USD
-0.14
-0.89%
Overview
Last close
15.59 usd
Market cap
2.83B usd
52 week high
16.89 usd
52 week low
13.07 usd
Target price
14.69 usd
Valuation
P/E
17.0377
Forward P/E
N/A
Price/Sales
0.1456
Price/Book Value
0.9156
Enterprise Value
1.86B usd
EV/Revenue
0.096
EV/EBITDA
5.644
Key financials
Revenue TTM
19.38B usd
Gross Profit TTM
1.39B usd
EBITDA TTM
345.04M usd
Earnings per Share
0.87 usd
Dividend
0.42 usd
Total assets
10.15B usd
Net debt
-983.76M usd
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.